help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Douglass, J. A.
Right arrow Articles by Holgate, S. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Douglass, J. A.
Right arrow Articles by Holgate, S. T.

Am. J. Respir. Crit. Care Med., Vol 150, No. 4, 10 1994, 1108-1113.

Influence of interleukin-8 challenge in the nasal mucosa in atopic and nonatopic subjects

JA Douglass, D Dhami, CE Gurr, M Bulpitt, JK Shute, PH Howarth, IJ Lindley, MK Church and ST Holgate
Immunopharmacology Group, University Medicine, Southampton General Hospital, England.

Interleukin-8 (IL-8) is a major cytokine in the recruitment of neutrophils (polymorphonuclear leukocytes) to areas of inflammation. It also activates T lymphocytes and cytokine-primed basophils and eosinophils and therefore may be implicated as an effector in allergic inflammation. IL-8 has also been identified as a mediator in such inflammatory pulmonary conditions as cystic fibrosis, allergen challenge, and sarcoidosis. To investigate the bioactivity of IL-8 in humans, we examined the effects of nasal challenge with human recombinant IL-8 in a double-blind placebo-controlled crossover study in which nasal resistance and rhinitic symptoms were monitored for 4 h after challenge. Cellular infiltration was quantified on differentially stained nasal smears obtained at hourly intervals. Cellular responses caused by in vivo priming were assessed by a comparison of atopic and nonatopic patient groups. A significant neutrophilic infiltrate in smear samples was observed in all patients challenged with IL-8 from 12 +/- 4% (mean +/- SEM) at baseline to 60 +/- 6% after 4 h; placebo challenge resulted in an increase in neutrophils to 30 +/- 4% (p < 0.04). Additionally, a significant increase in cumulative eosinophil recruitment occurred over the challenge period. Nasal resistance was significantly increased 10 min after instillation of IL-8 in all subjects compared with placebo, but there was no difference between atopic and nonatopic subjects. Nasal rhinitic symptoms were also increased in all subjects receiving IL-8 compared with placebo. In a further study in 19 subjects, nasal biopsy was performed 3 h after IL-8 or placebo challenge.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
ChestHome page
J. R. Hurst, T. M. A. Wilkinson, W. R. Perera, G. C. Donaldson, and J. A. Wedzicha
Relationships Among Bacteria, Upper Airway, Lower Airway, and Systemic Inflammation in COPD
Chest, April 1, 2005; 127(4): 1219 - 1226.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
R. Ronchetti, M. P. Villa, S. Martella, S. La Grutta, F. Ronchetti, G. Luca Biscione, J. Pagani, C. Falasca, F. Guglielmi, and M. Barreto
Nasal Cellularity in 183 Unselected Schoolchildren Aged 9 to 11 Years
Pediatrics, December 1, 2002; 110(6): 1137 - 1142.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. A. D. COOPER Jr., A. L. RIDGEWAY, J. PEARSON, and R. R. CULBRETH
Attenuation of Interleukin 8-induced Nasal Inflammation by an Inhibitor Peptide
Am. J. Respir. Crit. Care Med., April 1, 2001; 163(5): 1198 - 1205.
[Abstract] [Full Text]


Home page
Eur Respir JHome page
P. Scheid, L. Kempster, U. Griesenbach, J.C. Davies, A. Dewar, P.P. Weber, W.H. Colledge, M.J. Evans, D.M. Geddes, and E.W.F.W. Alton
Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence
Eur. Respir. J., January 1, 2001; 17(1): 27 - 35.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. H. Ulfman, D. P. H. Joosten, J. A. M. van der Linden, J.-W. J. Lammers, J. J. Zwaginga, and L. Koenderman
IL-8 Induces a Transient Arrest of Rolling Eosinophils on Human Endothelial Cells
J. Immunol., January 1, 2001; 166(1): 588 - 595.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
K F Chung and P J Barnes
Cytokines in asthma
Thorax, September 1, 1999; 54(9): 825 - 857.
[Full Text]


Home page
Pharmacol. Rev.Home page
P. J. Barnes, K. F. Chung, and C. P. Page
Inflammatory Mediators of Asthma: An Update
Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Yuta, W. J. Doyle, E. Gaumond, M. Ali, L. Tamarkin, J. N. Baraniuk, M. Van Deusen, S. Cohen, and D. P. Skoner
Rhinovirus infection induces mucus hypersecretion
Am J Physiol Lung Cell Mol Physiol, June 1, 1998; 274(6): L1017 - L1023.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. KUNA, R. ALAM, U. RUTA, and P. GORSKI
RANTES Induces Nasal Mucosal Inflammation Rich in Eosinophils, Basophils, and Lymphocytes In Vivo
Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): 873 - 879.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. Hiltermann, C. de Bruijne, J Stolk, A. Zwinderman, F. Spieksma, W Roemer, P. Steerenberg, P. Fischer, L van Bree, and P. Hiemstra
Effects of photochemical air pollution and allergen exposure on upper respiratory tract inflammation in asthmatics
Am. J. Respir. Crit. Care Med., December 1, 1997; 156(6): 1765 - 1772.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1994 American Thoracic Society